App aims to help melanoma survivors catch skin cancer early
NCT ID NCT05373823
First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This study tests whether a digital tool called MySmartSkin can help melanoma survivors do better skin self-exams. About 385 survivors will use either the enhanced app or a standard educational webpage. The goal is to see if the app leads to more thorough skin checks and earlier detection of new melanomas.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MySmartSkin web application
- What this could lead to
- If it works, this could give melanoma survivors a simple, effective way to catch new or returning skin cancers early.
- What could go wrong
- This is a behavioral study, not a treatment trial. It may not prove that the app reduces deaths, and results depend on people actually using it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rutgers Cancer Institute of New Jersey
RECRUITINGNew Brunswick, New Jersey, 08901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can new drug cocktails reawaken the immune system against melanoma?
- Could a Six-Month exercise and diet plan shield muscle during melanoma treatment?
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Can a One-Two punch of immune boosters revive cancer treatment?
- Can a modified herpes virus turn the tide against advanced cancer?
- Can your genes predict your melanoma risk?